These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 36913073)

  • 1. First Reported Case of Malignant Ectomesenchymoma with p.Leu122Arg Mutation in MYOD1 Gene: Extensive Intra- and Extracranial Tumor in a 15-Year-Old Female.
    Pena-Burgos EM; De Sabando DP; Utrilla C; Pozo-Kreilinger JJ; Sastre A; Rubio P; Escudero A; Mendiola-Sabio M; Pérez-Martínez A
    Head Neck Pathol; 2023 Sep; 17(3):855-863. PubMed ID: 36913073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A recurrent neomorphic mutation in MYOD1 defines a clinically aggressive subset of embryonal rhabdomyosarcoma associated with PI3K-AKT pathway mutations.
    Kohsaka S; Shukla N; Ameur N; Ito T; Ng CK; Wang L; Lim D; Marchetti A; Viale A; Pirun M; Socci ND; Qin LX; Sciot R; Bridge J; Singer S; Meyers P; Wexler LH; Barr FG; Dogan S; Fletcher JA; Reis-Filho JS; Ladanyi M
    Nat Genet; 2014 Jun; 46(6):595-600. PubMed ID: 24793135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ectomesenchymoma with embryonal rhabdomyosarcoma and ganglioneuroma, arising in association with benign triton tumor of the tongue.
    VandenHeuvel KA; Carpentieri DF; Chen J; Fung KM; Parham DM
    Pediatr Dev Pathol; 2014; 17(3):226-30. PubMed ID: 24650353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recurrent MYOD1 mutations in pediatric and adult sclerosing and spindle cell rhabdomyosarcomas: evidence for a common pathogenesis.
    Agaram NP; Chen CL; Zhang L; LaQuaglia MP; Wexler L; Antonescu CR
    Genes Chromosomes Cancer; 2014 Sep; 53(9):779-87. PubMed ID: 24824843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MYOD1 (L122R) mutations are associated with spindle cell and sclerosing rhabdomyosarcomas with aggressive clinical outcomes.
    Rekhi B; Upadhyay P; Ramteke MP; Dutt A
    Mod Pathol; 2016 Dec; 29(12):1532-1540. PubMed ID: 27562493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Malignant Ectomesenchymoma: Series Analysis of a Histologically and Genetically Heterogeneous Tumor.
    Griffin BB; Chou PM; George D; Jennings LJ; Arva NC
    Int J Surg Pathol; 2018 May; 26(3):200-212. PubMed ID: 28994342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The expanding morphological and genetic spectrum of MYOD1-mutant spindle cell/sclerosing rhabdomyosarcomas: a clinicopathological and molecular comparison of mutated and non-mutated cases.
    Tsai JW; ChangChien YC; Lee JC; Kao YC; Li WS; Liang CW; Liao IC; Chang YM; Wang JC; Tsao CF; Yu SC; Huang HY
    Histopathology; 2019 May; 74(6):933-943. PubMed ID: 30604891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genomic analysis and preclinical xenograft model development identify potential therapeutic targets for MYOD1-mutant soft-tissue sarcoma of childhood.
    Ting MA; Reuther J; Chandramohan R; Voicu H; Gandhi I; Liu M; Cortes-Santiago N; Foster JH; Hicks J; Nuchtern J; Scollon S; Plon SE; Chintagumpala M; Rainusso N; Roy A; Parsons DW
    J Pathol; 2021 Sep; 255(1):52-61. PubMed ID: 34086347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequent HRAS Mutations in Malignant Ectomesenchymoma: Overlapping Genetic Abnormalities With Embryonal Rhabdomyosarcoma.
    Huang SC; Alaggio R; Sung YS; Chen CL; Zhang L; Kao YC; Agaram NP; Wexler LH; Antonescu CR
    Am J Surg Pathol; 2016 Jul; 40(7):876-85. PubMed ID: 26872011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beyond "Triton": Malignant Peripheral Nerve Sheath Tumors With Complete Heterologous Rhabdomyoblastic Differentiation Mimicking Spindle Cell Rhabdomyosarcoma.
    Hornick JL; Nielsen GP
    Am J Surg Pathol; 2019 Oct; 43(10):1323-1330. PubMed ID: 31107719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytomorphology of spindle cell/sclerosing rhabdomyosarcoma, including MYOD1 (LI22R) mutation result.
    Rekhi B; Dodd L; Dharavath B; Dutt A
    Diagn Cytopathol; 2022 Dec; 50(12):E367-E372. PubMed ID: 35929754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Malignant ectomesenchymoma of the nose. Case report and review of the literature.
    Brehmer D; Overhoff HM; Marx A
    ORL J Otorhinolaryngol Relat Spec; 2003; 65(1):52-6. PubMed ID: 12624508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A MYOD1 mutation cooperates with PI3K pathway activation in ERMS.
    Cancer Discov; 2014 Jul; 4(7):OF19. PubMed ID: 25002625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. More Than Meets the Eye? A Cautionary Tale of Malignant Ectomesenchymoma Treated as Low-risk Orbital Rhabdomyosarcoma.
    Rashid T; Bagatell R; Pawel B; Bentley RC; Kreissman SG; Deel MD
    J Pediatr Hematol Oncol; 2021 Aug; 43(6):e854-e858. PubMed ID: 32769567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pelvic malignant ectomesenchymoma: a case report].
    Paramelle O; Croué A; Dupré F; Rialland X; Saint-André JP
    Ann Pathol; 2001 Aug; 21(4):344-7. PubMed ID: 11685134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A case of primary spindle cell variant of embryonal rhabdomyosarcoma of the prostate.
    Asahina M; Saito T; Arakawa A; Suehara Y; Takagi T; Hisasue S; Kaneko K; Horie S; Yao T
    Int J Clin Exp Pathol; 2014; 7(8):5181-5. PubMed ID: 25197394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Spindle cell/sclerosing rhabdomyosarcoma: a clinicopathological study of 20 cases].
    Yang L; Zhang HJ; Yang SJ
    Zhonghua Bing Li Xue Za Zhi; 2020 Apr; 49(4):336-342. PubMed ID: 32268670
    [No Abstract]   [Full Text] [Related]  

  • 18. DICER1-mutated rhabdomyosarcoma of the ovary with teratoid features.
    Lethongsavarn V; Vieille P; Kikweta Makhama J; Azmani R; Lafrance W; Khneisser P; Truffaut N; Alame M; Genestie C; Gaspar N; Diedhiou A; Croce S; Le Loarer F
    Genes Chromosomes Cancer; 2023 Dec; 62(12):746-754. PubMed ID: 37706559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional impact and targetability of
    Choo F; Odintsov I; Nusser K; Nicholson KS; Davis L; Corless CL; Stork L; Somwar R; Ladanyi M; Davis JL; Davare MA
    Cold Spring Harb Mol Case Stud; 2022 Jan; 8(1):. PubMed ID: 35012940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Discovery of a new mutation in MYOD1 characterizes a subset of aggressive embryonal rhabdomyosarcoma partnering with mutations of the PI3K-AKT pathway].
    Orbach D
    Bull Cancer; 2014 Sep; 101(9):776-7. PubMed ID: 25295632
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.